NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 4, 2014, Pages 499-504

  Meddour, Y ^a   Chaib, S ^a   Bousseloub, A ^a   Kaddache, N ^b   Kecili, L ^b   Gamar, L ^b   Nakkemouche, M ^c   Djidjik, R ^d,f   Abbadi, M C ^e,f   Charron, D ^g   Boucekkine, T E ^b   Tamouza, R ^g  

^a Hopital Central de l'Armee   (Algeria)

^b CHU Mustapha   (Algeria)

^c Parnet Hospital   (Algeria)

^d Centre Hospitalier et Universitaire de Beni Messous Algiers   (Algeria)

^e Institut Pasteur d'Algerie   (Algeria)

^f Immunogenetics and Immunopathology Research Laboratory   (Algeria)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGERIAN; ARTICLE; CARD15 GENE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL23R GENE; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; OUTCOME ASSESSMENT; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ALGERIA; GENETICS; MUTATION;

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; NOD2 PROTEIN, HUMAN;

ADULT; ALGERIA; CASE-CONTROL STUDIES; CROHN DISEASE; GENETIC VARIATION; HUMANS; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, INTERLEUKIN;

EID: 84912532129     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.02.003     Document Type: Article

References (33)

1. Probert C.S., Jayanthi V., Rampton D.S., Mayberry J.F. Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues. Int J Colorectal Dis 1996, 11(1):25-28.
2. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3(7):390-407.
3. Orchard T.R., Satsangi J., Van Heel D., Jewell D.P. Genetics of inflammatory bowel disease: a reappraisal. Scand J Immunol 2000, 51(1):10-17.
4. Binder V., Orholm M. Familial occurrence and inheritance studies in inflammatory bowel disease. Neth J Med 1996, 48(2):53-56.
5. Cavanaugh J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 2001, 68(5):1165-1171.
6. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996, 379(6568):821-823.
7. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603.
8. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002, 70(4):845-857.
9. Hampe J., Grebe J., Nikolaus S., Solberg C., Croucher P.J., Mascheretti S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002, 359(9318):1661-1665.
10. Binion D.G., Kugathasan S., Dwinell M.B. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. Am J Gastroenterol 2006, 101(1):107-109.
11. Crawford N.P., Colliver D.W., Eichenberger M.R., Funke A.A., Kolodko V., Cobbs G.A., et al. CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status. Dig Dis Sci 2007, 52(10):2716-2724.
12. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122(4):867-874.
13. Lakatos L., Lakatos P.L., Willheim-Polli C., Reinisch W., Ferenci P., Tulassay Z., et al. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease, Hungarian multicenter study]. Orv Hetil 2004, 145(27):1403-1411.
14. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463.
15. Bonen D.K., Ogura Y., Nicolae D.L., Inohara N., Saab L., Tanabe T., et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003, 124(1):140-146.
16. Vermeire S., Wild G., Kocher K., Cousineau J., Dufresne L., Bitton A., et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002, 71(1):74-83.
17. Ahmad T., Armuzzi A., Bunce M., Mulcahy-Hawes K., Marshall S.E., Orchard T.R., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002, 122(4):854-866.
18. Sugimura K., Taylor K.D., Lin Y.C., Hang T., Wang D., Tang Y.M., et al. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 2003, 72(3):509-518.
19. Inoue N., Tamura K., Kinouchi Y., Fukuda Y., Takahashi S., Ogura Y., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002, 123(1):86-91.
20. Yamazaki K., Takazoe M., Tanaka T., Kazumori T., Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002, 47(9):469-472.
21. Croucher P.J., Mascheretti S., Hampe J., Huse K., Frenzel H., Stoll M., et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003, 11(1):6-16.
22. Cavanaugh J.A., Adams K.E., Quak E.J., Bryce M.E., O'Callaghan N.J., Rodgers H.J., et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003, 67(Pt 1):35-41.
23. Azzam N., Nounou H., Alharbi O., Aljebreen A., Shalaby M. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's DIsease. Int J Mol Sci 2014, 13(4):4268-42680.
24. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., Abbott W.G., et al. Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand Crohn's disease patients. Immunol Cell Biol 2005, 83(5):498-503.
25. Bairead E., Harmon D.L., Curtis A.M., Kelly Y., O'Leary C., Gardner M., et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003, 11(3):237-244.
26. Hama I., Ratbi I., Reggoug S., Elkerch F., Kharrasse G., Errabih I., et al. Non-association of Crohn's disease with NOD2 gene variants in Moroccan patients. Gene 2014, 499(1):121-123.
27. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., Ioannidis J.P. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004, 99(12):2393-2404.
28. Chua K.H., Hilmi I., Lian L.H., Patmanathan S.N., Hoe S.Z., Lee W.S., et al. Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease. J Dig Dis 2014, 13(9):459-465.
29. Ellinghaus D., Ellinghaus E., Nair R.P., Stuart P.E., Esko T., Metspalu A., et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 2014, 90(4):636-647.
30. Naser S.A., Arce M., Khaja A., Fernandez M., Naser N., Elwasila S., et al. Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis. World J Gastroenterol 2014, 18(5):412-424.
31. Kanaan Z.M., Eichenberger M.R., Ahmad S., Weller C., Roberts H., Pan J., et al. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population. J Negat Results Biomed 2014, 11:7.
32. Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3(4):e58.
33. Csongei V., Jaromi L., Safrany E., Sipeky C., Magyari L., Farago B., et al. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. World J Gastroenterol 2014, 16(2):176-183.